Inhaled Corticosteroid Growth Studies Need Rescue Medication Plan – FDA
Studies evaluating the effect of orally inhaled and intranasal corticosteroids on growth in children should include an action plan for how to treat worsening symptoms, an FDA draft guidance recommends
You may also be interested in...
FDA's final guidance on studying the effects of inhaled and intranasal corticosteroids on growth in children narrows the recommended lower age limit for patients to three years of age
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011